Oligonucleotides-assembled au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of doxorubicin and cisplatin prodrug

ACS Applied Materials and Interfaces

Volumn 6, Issue 6, 2014, Pages 4382-4393

  Shanmugam, Vijayakumar ^a   Chien, Yi Hsin ^a   Cheng, Yu Sheng ^a   Liu, Tzu Yu ^a   Huang, Chih Chia ^b   Su, Chia Hao ^c   Chen, Yu Sen ^a   Kumar, Umesh ^a   Hsu, Hua Fen ^a   Yeh, Chen Sheng ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL UNIVERSITY OF KAOHSIUNG   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Au nanorod; Combination chemotherapy; dual drug delivery; hyperthermia; photothermal ablation

Indexed keywords

ABLATION; CHEMOTHERAPY; DRUG DELIVERY; FUNCTIONAL GROUPS; NANORODS; NUCLEIC ACIDS; OLIGONUCLEOTIDES; PLATINUM; PLATINUM COMPOUNDS;

AMINE FUNCTIONAL GROUPS; AU NANO RODS; COMBINATION CHEMOTHERAPY; DOUBLE STRANDED DNA; EXTERNAL STIMULUS; HYPERTHERMIA; PHOTOTHERMAL ABLATION; SINGLE-STRANDED DNA;

GOLD;

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; DRUG CARRIER; FOLATE RECEPTOR; NANOTUBE; OLIGONUCLEOTIDE; PRODRUG;

ANIMAL; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; EQUIPMENT; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; NEOPLASM; NUDE MOUSE; PHOTOTHERAPY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FOLATE RECEPTORS, GPI-ANCHORED; HUMANS; MALE; MICE; MICE, NUDE; NANOTUBES; NEOPLASMS; OLIGONUCLEOTIDES; PHOTOTHERAPY; PRODRUGS;

EID: 84897017039     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/am5000905     Document Type: Article

References (38)

1. Jia, J.; Zhu, F.; Ma, X.; Cao, Z. W.; Li, Y. X.; Chen, Y. Z. Mechanisms of Drug Combinations: Interaction and Network Perspectives Nat. Rev. Drug Discovery 2009, 8, 111-128
2. Lehár, J.; Krueger, A. S.; Avery, W.; Heilbut, A. M.; Johansen, L. M.; Price, E. R.; Rickles, R. J.; Short, G. F.; Staunton, J. E.; Jin, X.; Lee, M. S.; Zimmermann, G. R.; Borisy, A. A. Synergistic Drug Combinations Tend to Improve Therapeutically Relevant Selectivity Nat. Biotechnol. 2009, 27, 659-666
3. Lee, J.; Park, J. O.; Kim, W. S.; Park, S. H.; Park, K. W.; Choi, M. S.; Lee, J. H.; Koh, K. C.; Paik, S. W.; Yoo, B. C.; Joh, J.; Kim, K.; Jung, C. W.; Park, Y. S.; Im, Y.-H.; Kang, W. K.; Lee, M. H.; Park, K. Phase II Study of Doxorubicin and Cisplatin in Patients with Metastatic Hepatocellular Carcinoma Cancer Chemother. Pharmacol. 2004, 54, 385-390
4. Thigpen, J. T.; Brady, M. F.; Homesley, H. D.; Malfetano, J.; DuBeshter, B.; Burger, R. A.; Liao, S. Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study J. Clin. Oncol. 2004, 22, 3902-3908
5. Aapro, M. S.; van Wijk, F. H.; Bolis, G.; Chevallier, B.; van der Burg, M. E. L.; Poveda, A.; de Oliveira, C. F.; Tumolo, S.; Scotto di Palumbo, V.; Piccart, M.; Franchi, M.; Zanaboni, F.; Lacave, A. J.; Fontanelli, R.; Favalli, G.; Zola, P.; Guastalla, J. P.; Rosso, R.; Marth, C.; Nooij, M.; Presti, M.; Scarabelli, C.; Splinter, T. A. W.; Ploch, E.; Beex, L. V. A.; Huinink, W. B.; Forni, M.; Melpignano, M.; Blake, P.; Kerbrat, P.; Mendiola, C.; Cervantes, A. A.; Goupil; Harper, P. G.; Madronal, C.; Namer, M.; Scarfone, G.; Stoot, J. E. G. M.; Teodorovic, I.; Coens, C.; Vergote, I.; Vermorken, J. B. Doxorubicin Versus Doxorubicin and Cisplatin in Endometrial Carcinoma: Definitive Results of a Randomised Study (55872) by the EORTC Gynaecological Cancer Group Ann. Oncol. 2003, 14, 441-448
6. Nielsen, D.; Larsen, P. D. S. K.; Skovsgaard, O. P. H. T. Epirubicin or Epirubicin and Cisplatin as First-Line Therapy in Advanced Breast Cancer. A phase III study Cancer Chemother. Pharmacol. 2000, 46, 459-466
7. Martoni, A.; Bellucco, A.; Canova, N.; Pannuti, F. Four-Year Analysis of Platinum and Anthracycline Combination for Ovarian Cancer Oncology 1989, 46, 109-116
8. Wang, X.; Liu, Q.; Hou, B.; Zhang, W.; Yan, M.; Jia, H.; Li, H.; Yan, D.; Zheng, F.; Ding, W.; Yi, C.; Wang, H. Concomitant Targeting of Multiple Key Transcription Factors Effectively Disrupts Cancer Stem Cells Enriched in Side Population of Human Pancreatic Cancer Cells PLoS One 2013, 8, e73942
9. Hu, C. M.; Aryal, S.; Zhang, L. F. Nanoparticle-Assisted Combination Therapies for Effective Cancer Treatment Ther. Delivery 2010, 1, 323-334
10. Davis, M. E.; Chen, Z.; Shin, D. M. Nanoparticle Therapeutics: an Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
11. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
12. Lee, S.-M.; OHalloran, T. V.; Nguyen, S. B. T. Polymer-Caged Nanobins for Synergistic Cisplatin-Doxorubicin Combination Chemotherapy J. Am. Chem. Soc. 2010, 132, 17130-17138
13. Kolishettia, N.; Dharc, S.; Valenciad, P. M.; Lind, L. Q.; Karnike, R.; Lippard, S. J.; Langer, R.; Farokhzad, O. C. Engineering of Self-Assembled Nanoparticle Platform For Precisely Controlled Combination Drug Therapy Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 17939-17944
14. Shuhendler, A. J.; Cheung, R. Y.; Manias, J.; Connor, A.; Rauth, A. M.; Wu, X. Y. A Novel Doxorubicin-Mitomycin C Co-encapsulated Nanoparticle Formulation Exhibits Anti-Cancer Synergy in Multidrug Resistant Human Breast Cancer Cells Breast Cancer Res. Treat. 2010, 119, 255-269
15. Wang, H.; Zhao, Y.; Wu, Y.; Hu, Y. L.; Nan, K.; Nie, G.; Chen, H. Enhanced Anti-Tumor Efficacy By Co-Delivery Of Doxorubicinand Paclitaxel With Amphiphilic Methoxy PEG-PLGA Copolymer Nanoparticles Biomaterials 2011, 32, 8281-8290
16. Singh, A.; Dilnawaz, F.; Mewar, S.; Sharma, U.; Jagannathan, N. R.; Sahoo, S. K. Composite Polymeric Magnetic Nanoparticles for Co-Delivery of Hydrophobic and Hydrophilic Anticancer Drugs and MRI Imaging for Cancer Therapy ACS Appl. Mater. Interfaces 2011, 3, 842-856
17. Kim, D.; Jeong, Y. Y.; Jon, S. A Drug-Loaded Aptamer-Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer ACS Nano 2010, 4, 3689-3696
18. Bagalkot, V.; Farokhzad, O. C.; Langer, R.; Jon, S. An Aptamer-Doxorubicin Physical Conjugate as a Novel Targeted Drug-Delivery Platform Angew. Chem., Int. Ed. 2006, 45, 8149-8152
19. Frederick, C. A.; Williams, L. D.; Ughetto, G.; van der Mare1, G. A.; van Boom, J. H.; Rich, A.; Wang, A. H. Structural Comparison of Anticancer Drug-DNA Complexes: Adriamycin and Daunomycin Biochemistry 1990, 29, 2538-2549
20. Hurst, S. J.; Lytton-Jean, A. K. R.; Mirkin, C. A. Maximizing DNA Loading on a Range of Gold Nanoparticle Sizes Anal. Chem. (Washington, DC, U. S.) 2006, 78, 8313-8318
21. Demers, L. M.; Mirkin, C. A.; Mucic, R. C.; Reynolds, R. A.; Letsinger, R. L.; Elghanian, R.; Viswanadham, G. A Fluorescence-Based Method for Determining the Surface Coverage and Hybridization Efficiency of Thiol-Capped Oligonucleotides Bound to Gold Thin Films and Nanoparticles Anal. Chem. (Washington, DC, U. S.) 2000, 72, 5535-5541
22. Barnes, K. R.; Kutikov, A.; Lippard, S. Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes Chem. Biol. 2004, 11, 557-564
23. Yang, J.; Liu, W.; Sui, M.; Tang, J.; Shen, Y. Platinum (IV)-Coordinate Polymers as Intracellular Reduction-Responsive Backbone-Type Conjugates for Cancer Drug Delivery Biomaterials 2011, 32, 9136-9143
24. Jana, N. R.; Gearheart, L.; Murphy, C. J. Wet Chemical Synthesis of High Aspect Ratio Cylindrical Gold Nanorods J. Phys. Chem. B 2001, 105, 4065-4067
25. Dhar, S.; Daniel, W. L.; Giljohann, D. A.; Mirkin, C. A.; Lippard, S. J. Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads J. Am. Chem. Soc. 2009, 131, 14652-14653
26. 67Ga-Deferoxamine-Folate, a Potential Radiopharmaceutical for Tumor Imaging Bioconjugate Chem. 1996, 7, 56-62
27. Martínez, R.; García, L.C. The Search of DNA-Intercalators as Antitumoral Drugs: What it Worked and What did not Work Curr. Med. Chem. 2005, 12, 127-151
28. Ihmels, H.; Otto, D. Intercalation of Organic Dye Molecules into Double-stranded DNA. Part 1: The Annelated Quinolizinium Ion as a Structural Motif in DNA Intercalators Top. Curr. Chem. 2005, 258, 161-204
29. Cashman, D. J.; Scarsdale, J. N.; Kellogg, G. E. Hydropathic Analysis of the Free Energy Differences in Anthracycline Antibiotic Binding to DNA Nucleic Acids Res. 2003, 31, 4410-4416
30. Huschka, R.; Zuloaga, J.; Knight, M. W.; Brown, L. V.; Nordlander, P.; Halas, N. J. Light-Induced Release of DNA from Gold Nanoparticles: Nanoshells and Nanorods J. Am. Chem. Soc. 2011, 133, 12247-12255
31. Santra, S.; Jativa, S. D.; Kaittanis, C.; Normand, G.; Grimm, J.; Perez, J. M. Gadolinium-Encapsulating Iron Oxide Nanoprobe as Activatable NMR/MRI Contrast Agent ACS Nano 2012, 6, 7281-7294
32. Kuo, W. S.; Chang, C. N.; Chang, Y. T.; Yeh, C. S. Antimicrobial Gold Nanorods with Dual-Modality Photodynamic Inactivation and Hyperthermia Chem. Commun. 2009, 45, 4853-4855
33. Hauck, T. S.; Jennings, T. L.; Yatsenko, T.; Kumaradas, J. C.; Chan, W. C. W. Enhancing the Toxicity of Cancer Chemotherapeutics with Gold Nanorod Hyperthermia Adv. Mater. 2008, 20, 3832-3838
34. Hahn, G. M.; Braun, J.; Har-Kedar, I. Thermochemotherapy: Synergism Between Hyperthermia (42-43 degrees) and Adriamycin (of Bleomycin) in Mammalian Cell Inactivation Proc. Natl. Acad. Sci. U. S. A. 1975, 72, 937-940
35. Liu, H. Y.; Chen, D.; Li, L. L.; Liu, T. L.; Tan, L. F.; Wu, X. L.; Tang, F. Q. Multifunctional Gold Nanoshells on Silica Nanorattle: A Novel Potential Platform for Combination of Photothermal Therapy and Chemotherapy with Low Systemic Toxicity Angew. Chem., Int. Ed. 2011, 50, 891-895
36. Lee, S. M.; Park, H.; Yoo, K. H. Synergistic Cancer Therapeutic Effects of Locally Delivered Drug and Heat Using Multifunctional Nanoparticles Adv. Mater. 2010, 22, 4049-4053
37. Bull, J. M. C. An Update on the Anticancer Effects of a Combination of Chemotherapy and Hyperthermia Cancer Res. 1984, 44, 4853-4856
38. Palzer, R. J.; Heidelberger, C. Influence of Drugs and Synchrony on the Hyperthermic Killing of HeLa Cells Cancer Res. 1973, 33, 422-427